Ampreloxetine (TD-9855)

ampelexotide? (Note: Ampreloxetine is the correct generic name; TD-9855 is the investigational code) · Theravance Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ampreloxetine (TD-9855), covering 2022-09-14 to 2022-09-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure [Phase 3]

See pricing